Brucellosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m (Changes made per Mahshid's request) |
m (Bot: Removing from Primary care) |
||
(One intermediate revision by one other user not shown) | |||
Line 11: | Line 11: | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Pulmonology]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Pulmonology]] | |||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category:Emergency medicine]] | |||
[[Category:Infectious disease]] | |||
Latest revision as of 20:45, 29 July 2020
Brucellosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Brucellosis secondary prevention On the Web |
American Roentgen Ray Society Images of Brucellosis secondary prevention |
Risk calculators and risk factors for Brucellosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]
Overview
Secondary prevention strategies of Brucellosis include follow up of the patient upto 2 years following the diagnosis of Brucellosis to monitor for relapse.
Secondary prevention
Secondary prevention strategies of Brucellosis include follow up of the patient upto 2 years following the diagnosis of Brucellosis to monitor for relapse and chronic brucellosis.[1]
Reference
- ↑ Brucellosis "Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo"Harrison's Principles of Internal Medicine, 19e Accessed on December 9th, 2017